HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention.

Publication Type:

Journal Article

Source:

Journal of acquired immune deficiency syndromes (1999) (2014)

Keywords:

2014, May 2014, Public Health Sciences Division, Vaccine and Infectious Disease Division

Abstract:

Antiretroviral pre-exposure prophylaxis (PrEP) is a novel HIV prevention strategy for which adherence is a known determinant of efficacy. Blood concentrations of PrEP medications are one objective marker of adherence.